Clinical trials, including the SURMOUNT-5 study, demonstrate tirzepatides ability to achieve 13.7-20.2% weight loss in individuals with obesity but without type 2 diabetes, outperforming other GLP-1 receptor agonists in direct comparisons
National Bureau of Economic Research, NBER Working Paper No
Quality Control & Packaging: The final product undergoes testing for purity and is packaged for cosmetic and skincare applications
Why Researchers Source the KLOW Blend from LiveWell Peptides LiveWell Peptides is a US-based cGMP peptide manufacturer headquartered in Dallas, Texas , supplying research-grade peptides and peptide blends to laboratories, universities and qualified independent researchers across the United States and internationally
Online peptides are typically research-grade, unregulated, and labeled "not for human use," with no guarantee of purity or safety
While our bodies naturally produce these vital compounds, supplementation can provide an invaluable boost to support your health